- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces First Quarter 2024 Results
- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 46.60 |
---|---|
High | 46.80 |
Low | 46.60 |
Bid | 46.40 |
Offer | 47.20 |
Previous close | 46.20 |
Average volume | 93.11 |
---|---|
Shares outstanding | 54.85m |
Free float | 51.69m |
P/E (TTM) | -- |
Market cap | 2.80bn USD |
EPS (TTM) | -1.89 USD |
Data delayed at least 15 minutes, as of May 23 2024 11:31 BST.
More ▼